The main change made in ATP III is the lowering of the levels of fasting glucose required to be considered impaired. This adjustment reduces the threshold for elevated fasting glucose from more than 110 milligrams per deciliter down to 100 mg/dL.The following picture shown a HealthWatch report of a female patient. Based on the new ATP III criteria, she is considered as having the metabolic syndrome because her fasting glucose level (105 mg/dL) is higher than 100 mg/dL, though is considered normal with old ATP III criteria.

HealthWatch identify metabolic syndrome and calculate risk for having a heart attack using the algorithms from ATP III. BVTech implemented the latest adjustment of ATP III into the new released version of HealthWatch. Visit the website of BVTech for free software downloads of HealthWatch. For health professionals in clinical and research settings, please download HealthWatch. Tools for importing and exporting mass data from Excel Sheets are available in HealthWatch Pro, which can help you to recalculate your data using the new algorithm.

BVTech was founded in 2000 in GA, USA. Its main businese is to provide software solutions for clients in clinical data management, and health researches.

Contact information:

E-mail: support@biovisualtech.com

Mail to: 770 Locks Way, Martinez, GA 30907

Click to enlarge